Stem Cells Overview
- 1 in 3 people may benefit from stem cell regenerative medicine therapy 1
- Nearly 80 diseases are FDA approved for routine treatment with cord blood stem cells
- Every four minutes, one person is diagnosed with a blood cancer
- Every ten minutes someone dies from a blood cancer
- About 1 in every 400 children and adolescents are diagnosed with diabetes
- About 10,000 babies per year in the U.S. will develop cerebral palsy
- Leukemia, lymphoma and myeloma will cause the deaths of an estimated 54,020 people in the United States this year 2
For the diseases listed above, and many others, stem cell therapies offer the greatest potential for a cure. Privately banking your baby's umbilical cord blood and cord tissue stem cells ensures that this precious resource will be readily available should a stem cell transplant be needed to save a family member’s life.
In 1988, only one disease was being treated with cord blood stem cells. In 1999, there were only two. Today, that list has exploded to include nearly 80 diseases and conditions, many of which were previously considered incurable. With over 700 clinical trials and numerous research studies currently in progress, it is estimated that as many as 1 in 3 people in the United States may benefit from regenerative medicine therapy with stem cells.1
1 Harris DT. Cord blood stem cells: a review of potential neurological applications. Stem Cell Rev. 2008;4:269-274. Epub August 5, 2008.
2 The Leukemia & Lymphoma Society. (August 19, 2010). Facts & Statistics. Retrieved September 2, 2010, from http://www.leukemia-lymphoma.org/all_page?item_id=12486